CNASRegulated (List II)EBASTA
MERINAL
Identification
- Active ingredient (INN)
- EBASTINE
- Internal code
- 01 A 056
- Country of Origin
- Algeria
- Pharmaceutical form
- Orodispersible Tablet
- Prescription List
- Regulated (List II)
- Packaging
- b/10 et b/30

CNASDAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Description
Ebastine is under investigation for the treatment of Irritable Bowel Syndrome (IBS).
Ebastine has been investigated for the treatment of Urticaria.
Indications
Not Available
Mechanism of Action
Ebastine is a second-generation antihistamine that acts as a selective histamine H1-receptor antagonist to relieve allergic symptoms.
H1 receptor antagonist Humans.
Metabolism
Hover over products below to view reaction partners Ebastine 4-(4-tert-butylphenyl)-4-oxobutanal + Deslakylebastine.
Adverse Effects
Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.